MBI

MBI (Michigan Biotechnology Institute) is a premier biotechnology accelerator and contract development and manufacturing organization (CDMO) focused on de-risking and scaling up bio-based technologies. Originally founded as a non-profit research institute, it now operates as a subsidiary of the Michigan State University Foundation, bridging the gap between university-scale discovery and commercial-scale manufacturing. MBI specializes in fermentation, downstream processing, and the development of bio-based chemicals, materials, and ingredients. The company is well-known for its collaborative 'de-risking' model, where it partners with both startups and established global corporations to accelerate the commercialization of sustainable technologies. Its capabilities span from bench-scale research to pilot-plant production, providing essential infrastructure for the industrial biotechnology sector.